Your browser version may not work well with NCBI's Web applications. More information here...
1: Science. 1996 Mar 15;271(5255):1582-6.Click here to read Links

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time.

Theoretical Division, Los Alamos National Laboratory, NM 87545, USA.

A new mathematical model was used to analyze a detailed set of human immunodeficiency virus-type 1 (HIV-1) viral load data collected from five infected individuals after the administration of a potent inhibitor of HIV-1 protease. Productively infected cells were estimated to have, on average, a life-span of 2.2 days (half-life t 1/2 = 1.6 days), and plasma virions were estimated to have a mean life-span of 0.3 days (t 1/2 = 0.24 days). The estimated average total HIV-1 production was 10.3 x 10(9) virions per day, which is substantially greater than previous minimum estimates. The results also suggest that the minimum duration of the HIV-1 life cycle in vivo is 1.2 days on average, and that the average HIV-1 generation time--defined as the time from release of a virion until it infects another cell and causes the release of a new generation of viral particles--is 2.6 days. These findings on viral dynamics provide not only a kinetic picture of HIV-1 pathogenesis, but also theoretical principles to guide the development of treatment strategies.

PMID: 8599114 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Ritonavir (Norvir® , Norvir® Softgel)

    Ritonavir is used to treat human immunodeficiency virus (HIV) infection. It belongs to a class of drugs called protease (pro' tee ace) inhibitors, which slow the spread of HIV infection in the body. It is usually taken w...